Jobs / United States / Glaxosmithkline LLC
Head, Global Market Access and Pricing, ViiV
Glaxosmithkline LLC · 🇺🇸 2 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles1 certified filing for “Associate Director - Global Regulatory Affairs, Oncology” (Regulatory Affairs Managers) in WA: $154k–$154k, median $154k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
Head, Global Market Access and Pricing, ViiV Healthcare Why ViiV ViiV Healthcare is the only company 100% focused on HIV. Our purpose is to get ahead of HIV together, our ambition is to help end the HIV and AIDS epidemic, and our mission is to leave no person living with HIV behind. Role Purpose: This role offers you the opportunity to lead global market access and pricing strategy for some of the most transformative medicines in HIV. You will help redefine payer, clinician, and patient perceptions of long-acting therapies, shape the future market environment, and ensure access to groundbreaking innovations to people living with and at risk of HIV across the globe. Lead the Global Market Access and Pricing function for ViiV Healthcare, building access and pricing strategies for the current and future portfolio. Working with cross-functional partners, the role ensures payer, HTA and pricing requirements are embedded early in asset strategy, target product profiles, Brand strategy, Integrated Evidence Plans, development decisions, value communication and launch readiness, enabling broad and timely access for people living with HIV and people who could benefit from prevention while protecting long-term portfolio value. As a key commercial leader within ViiV and a member of the Global Commercial Strategy Leadership Team, the role provides an enterprise leadership opportunity. Key Responsibilities: Portfolio access and value strategy & execution • Design global product and portfolio pricing and access strategies that support access while delivering long-term value for ViiV Healthcare. • Lead development of differentiated payer value propositions, value communication tools, pricing strategies and access plans for launch, pipeline and lifecycle assets. • Partner with R&D, Commercial, Medical/Health Outcomes, RWE, Government Affairs, Policy, Finance and Regional/Local teams to secure early payer insights and needs are into asset strategy and development decisions. • Ensure Payer insights and needs are represented in strategy development, forecasting, launch & indication sequencing, integrated evidence generation plans, business planning, and launch excellence processes. • Support Region and key LOCs with pricing & access strategy localization, launch preparation and launch risk mitigation. • Optimise global-to-local ways of working through best-practice sharing, performance metrics, clear accountabilities and integration with pricing and HTA trends. • Execute plans effectively through Region and LOC plans, focusing on excellent operationalisation and implementation of strategy. Ensure a clear focus on outcomes and behaviour change, not activity. • Deliver measurable positive impact of pricing and access strategies on product and portfolio outcomes. External environment • Increase payer, HTA and policymaker receptivity to the value of HIV innovation • Monitor payer, HTA, policy, pricing and competitor trends globally, and distil implications with scenario planning and recommendations as appropriate. Pricing governance and value preservation • Chair and evolve the global Price Governance framework, overseeing price setting, price maintenance and alignment to global access and pricing strategy. • Document, monitor and assess the effectiveness, risk and financial exposure of pricing and access decisions, escalating insights for proactive management as required. Leadership, talent and capability • Lead the Global Market Access and Pricing team • Attract, recruit, onboard, retain and develop diverse talent and expertise, using clear objectives, development plans and coaching for each team member. • Enhance performance culture, challenger mindset, decision-making courage and accountability across the global ma